Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Colorcon
Johnson and Johnson
McKesson
Dow

Last Updated: December 4, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206681


Email this page to a colleague

« Back to Dashboard

NDA 206681 describes OXACILLIN SODIUM, which is a drug marketed by Ani Pharms, Apothecon, Teva, Aurobindo Pharma Ltd, Elkins Sinn, Fresenius Kabi Usa, Hospira Inc, Istituto Bio Ita Spa, Mylan Labs Ltd, Piramal Critical, Sagent Pharms, Sandoz, Watson Labs Inc, and Wockhardt Bio Ag, and is included in twenty-three NDAs. It is available from five suppliers. Additional details are available on the OXACILLIN SODIUM profile page.

The generic ingredient in OXACILLIN SODIUM is oxacillin sodium. There are thirty-eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.
Summary for 206681
Tradename:OXACILLIN SODIUM
Applicant:Piramal Critical
Ingredient:oxacillin sodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 206681
Medical Subject Heading (MeSH) Categories for 206681
Suppliers and Packaging for NDA: 206681
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 206681 ANDA Piramal Critical Care Inc 66794-225 66794-225-41 10 VIAL in 1 CARTON (66794-225-41) > 1 g in 1 VIAL (66794-225-02)
OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 206681 ANDA Piramal Critical Care Inc 66794-226 66794-226-41 10 VIAL in 1 CARTON (66794-226-41) > 2 g in 1 VIAL (66794-226-02)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1GM BASE/VIAL
Approval Date:Sep 11, 2017TE:APRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 2GM BASE/VIAL
Approval Date:Sep 11, 2017TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Johnson and Johnson
Moodys
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.